Impacto de los mensajes de prevención de cigarrillos electrónicos en los adolescentes
The purpose of this trial is to determine whether a vaping prevention text message program reduces susceptibility to vaping among adolescents and young adults. This study addresses this issue by exposing participants to a vaping prevention text message program over a 28-day period in a randomized controlled trial with a matched attention control condition. A follow-up assessment is also made 4 weeks after the text messaging ends.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Tobacco prevention communication is a key tool for reducing tobacco use among adolescents and young adults. While the use of e-cigarettes and vaping has increased greatly among adolescents and young adults, there has been a dearth of research on effective communication strategies to reduce vaping. This study will test the impact of a text-messaging program on reducing susceptibility to vaping in a randomized controlled trial, illuminating whether such programs can be effective. The investigators focus on adolescents and young adults (ages 13-20) who currently vape or who are at risk of vaping.
Participants will be randomly assigned to receive either a vaping prevention text message program or a wellness text message program (control). Participants in the study will take 4 online surveys over an 8-week period - at Visit 1 (baseline), Visit 2 (2 weeks), Visit 3 (4 weeks), and Visit 4 (8 weeks).
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
North Carolina
-
Chapel Hill, North Carolina, Estados Unidos, 27599
- University of North Carolina, Chapel Hill
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Ages 13-20 years old (inclusive)
- Have a phone that sends and receives text messages
- Ever vaped or are susceptible to using e-cigarettes or vaping
Exclusion Criteria:
- None
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Vaping prevention text messages
Participants will receive text messages (2 daily, on average) about the harms of e-cigarette use and vaping for 28 days, with introductory messages sent on day 1 and concluding messages sent on day 28. |
Participants will receive text messages (2 daily, on average) about the harms of e-cigarette use and vaping for 28 days, with introductory messages sent on day 1 and concluding messages sent on day 28. Each vaping prevention text message will focus on one of six topics: nicotine addiction, monetary costs of vaping, chemical exposures from e-cigarette vapor, cosmetic effects of vaping, mental and physical use symptoms of vaping, and health impact on organs from vaping. Some text messages will ask participants for a reply (i.e., two-way messages). |
|
Comparador activo: Wellness behavior text messages
Participants will receive text messages (2 daily, on average) about general wellness topics, with introductory messages sent on day 1 and concluding messages sent on day 28. |
Participants will receive text messages (2 daily, on average) about general wellness topics, with introductory messages sent on day 1 and concluding messages sent on day 28. Each wellness text message will focus on one of six topics: sleep hygiene, safe driving, sun safety, study habits, nutrition, and exercise. This attention control condition is matched with the intervention condition in that participants will receive the same number of text messages over the same number of days, the same intervention structure (e.g., 6 topics), and the same number and types of two-way messages. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Mean Susceptibility to Vaping Score
Periodo de tiempo: Visit 3 (4 weeks)
|
The mean susceptibility to vaping score will be assessed using the questionnaire. Response options are on a 1 to 4 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-4), with higher scores representing a greater susceptibility to vaping (a worse outcome). |
Visit 3 (4 weeks)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Mean Vaping Instrumental Attitudes Score
Periodo de tiempo: Visit 3 (4 weeks)
|
The mean vaping instrumental attitudes score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores representing a belief that vaping is more beneficial, safe and healthy. |
Visit 3 (4 weeks)
|
|
Mean Vaping Affective Attitudes Score
Periodo de tiempo: Visit 3 (4 weeks)
|
.The mean vaping affective attitudes score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores representing a belief that vaping is more enjoyable, pleasant, and fun. |
Visit 3 (4 weeks)
|
|
Mean Vaping Addiction Risk Beliefs Score
Periodo de tiempo: Visit 3 (4 weeks)
|
The mean vaping addiction risk beliefs score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores representing more tendency to addiction. |
Visit 3 (4 weeks)
|
|
Mean Vaping Monetary Cost Beliefs Score
Periodo de tiempo: Visit 3 (4 weeks)
|
The mean vaping monetary cost beliefs score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores represents participants' believes that vaping is a costly activity. |
Visit 3 (4 weeks)
|
|
Mean Vaping Chemical Risk Beliefs Score
Periodo de tiempo: Visit 3 (4 weeks)
|
The mean vaping chemical risk beliefs score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores representing participant's believes that e-cigarette vapor contains chemicals that pose health risks. |
Visit 3 (4 weeks)
|
|
Mean Vaping Cosmetic Risk Beliefs Score
Periodo de tiempo: Visit 3 (4 weeks)
|
The mean vaping cosmetic risk beliefs score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores representing participant belief that use will harm their cosmetic appearance. |
Visit 3 (4 weeks)
|
|
Mean Vaping Health Symptoms Beliefs Score
Periodo de tiempo: Visit 3 (4 weeks)
|
The mean vaping physical symptoms of use beliefs score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores represent participant believes that e-cigarette use will cause certain physical symptoms. |
Visit 3 (4 weeks)
|
|
Mean Vaping Mental Health Symptoms of Use Beliefs Score
Periodo de tiempo: Visit 3 (4 weeks)
|
The mean vaping mental health symptoms of use beliefs score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores represent participant believes that e-cigarette use will cause or worsen mental health symptoms. |
Visit 3 (4 weeks)
|
|
Mean Vaping Health Organ Risk Beliefs Score
Periodo de tiempo: Visit 3 (4 weeks)
|
The mean vaping health organ risk beliefs score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores representing participant believes that e-cigarette use will harm the health of certain organs. |
Visit 3 (4 weeks)
|
|
Mean Susceptibility to Smoking Cigarettes Score
Periodo de tiempo: Visit 3 (4 weeks)
|
The mean susceptibility to smoking cigarettes score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores represent participant more open to smoking. |
Visit 3 (4 weeks)
|
|
Mean Smoking Instrumental Attitude Score
Periodo de tiempo: Visit 3 (4 weeks)
|
The 1-item mean smoking instrumental attitude measure assesses a participant's attitude toward smoking. Response options are on a 1 to 5 scale, with higher scores representing a more harmful perception of smoking. |
Visit 3 (4 weeks)
|
|
Mean Smoking Affective Attitude Score
Periodo de tiempo: Visit 3 (4 weeks)
|
The 1-item mean smoking affective attitude measure assesses a participant's attitude toward smoking (unenjoyable/enjoyable). Response options are on a 1 to 5 scale, with higher scores representing a more enjoyable attitude toward smoking. |
Visit 3 (4 weeks)
|
|
Mean Smoking Addiction Risk Belief Score
Periodo de tiempo: Visit 3 (4 weeks)
|
The 1-item mean smoking addiction risk belief measure assesses the extent to which a participant believes that smoking will lead to addiction. Response options are on a 1 to 5 scale, with higher scores representing beliefs that smoking will lead to addiction. |
Visit 3 (4 weeks)
|
|
Mean Smoking Health Harm Risk Belief Score
Periodo de tiempo: Visit 3 (4 weeks)
|
The 1-item mean smoking health harm risk belief measure assesses the extent to which a participant believes that smoking will lead to health harm. Response options are on a 1 to 5 scale, with higher scores representing higher beliefs that smoking will cause to health harm. |
Visit 3 (4 weeks)
|
|
Mean Vaping Injunctive Norms Score
Periodo de tiempo: Visit 3 (4 weeks)
|
The 3-item mean vaping injunctive norms scale assesses a participant's perception of others' approval or disapproval of their vaping behavior. Response options are on a 1 to 5 scale. Overall scores are determined by summing the scores of the 3 items and dividing them by 3 (range 1-5), with higher scores representing a participant's perception of others' approval about vaping. |
Visit 3 (4 weeks)
|
|
Mean Vaping Refusal Self-efficacy Score
Periodo de tiempo: Visit 3 (4 weeks)
|
The 3-item mean vaping refusal self-efficacy scale assesses a participant's confidence that they could refuse to vape in a social situation. Response options are on a 1 to 5 scale. Overall scores are determined by summing the scores of the 3 items and dividing them by 3 (range 1-5), with higher scores representing a higher amount of refuse to vape in a social situation. |
Visit 3 (4 weeks)
|
|
Frequency of Vaping
Periodo de tiempo: Visit 3 (4 weeks)
|
Participants will be asked the number of days they vaped over the past 30 days, with higher scores indicating more days vaped. |
Visit 3 (4 weeks)
|
|
Frequency of Cigarette Smoking
Periodo de tiempo: Visit 3 (4 weeks)
|
Participants will be asked the number of days they smoked cigarettes over the past 30 days, with higher scores indicating more days smoked. |
Visit 3 (4 weeks)
|
|
Frequency of Using Other Tobacco Products
Periodo de tiempo: Visit 3 (4 weeks)
|
Participants will be asked if they used other tobacco products (OTP) over the past 30 days. OTP use will be determined as follows: no use = person who doesn't use OTPs; used = person who uses OTPs; no response = person who skipped or refused to answer |
Visit 3 (4 weeks)
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Seth Noar, PhD, UNC Lineberger Comprehensive Cancer Center
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 20-1245
- 5R01DA049155-02 (Subvención/contrato del NIH de EE. UU.)
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .